Initial clinical experience of ranibizumab therapy for neovascular age-related macular degeneration
Tryfon Rotsos, Praveen J Patel, Fred K Chen, Adnan TufailMedical Retina Service, Moorfields Eye Hospital, London, UKPurpose: To describe the visual acuity and safety outcomes for the first 50 patients with neovascular age-related macular degeneration (nAMD) treated with ranibizumab at Moorfields Eye...
Guardado en:
Autores principales: | Tryfon Rotsos, Praveen J Patel, Fred K Chen, et al |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://doaj.org/article/dd4fa73667e04d26ba0577c29b9925d7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Radiation therapy for neovascular age-related macular degeneration
por: Robert Petrarca, et al.
Publicado: (2011) -
Visual outcome of ranibizumab therapy for neovascular age related macular degeneration in the black population: a report of five cases
por: Roopa Vemala, et al.
Publicado: (2010) -
Intravitreal ranibizumab for symptomatic drusenoid pigment epithelial detachment without choroidal neovascularization in age-related macular degeneration
por: Roberto Gallego-Pinazo, et al.
Publicado: (2011) -
Foveal atrophy and macular hole formation following intravitreal ranibizumab with/without photodynamic therapy for choroidal neovascularization secondary to age-related macular degeneration
por: Pukhraj Rishi, et al.
Publicado: (2011) -
Initial non-responders to ranibizumab in the treatment of age-related macular degeneration (AMD)
por: Otsuji T, et al.
Publicado: (2013)